Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
V-pH is an oral probiotic capsule developed by Ordain Health Care (an Exeltis company) to support and maintain vaginal health. The formulation contains a blend of four beneficial Lactobacillus strains: Lactobacillus crispatus, Lactobacillus rhamnosus, Lactobacillus gasseri, and Lactobacillus jensenii. These probiotics work synergistically to colonize the vaginal microflora, produce lactic acid and hydrogen peroxide, and maintain an optimal acidic pH. This helps prevent vaginal dysbiosis, bacterial vaginosis, and other common urogenital infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on V-pH.